Dr. Abigail Zamorano of McGovern Medical School at UT Health Houston discusses groundbreaking advancements in cervical cancer treatment, including immunotherapy and antibody-drug conjugates for recurrent disease.
[ACT]IVATION TIP
“…remember how far we’ve come in just even a short amount of time and all of these new advancements and thinking about that these advancements have only been made possible with clinical trials. So more clinical trials are in the pipeline. I really encourage providers and patients to think and consider clinical trials when they’re at a juncture point of their cancer-directed therapy..”
Related Resources
Transcript
Lisa Hatfield:
Dr. Zamorano, what are exciting advancements in cervical cancer treatment that are on the horizon?
Dr. Abigail Zamorano:
This is a great question. There are so many exciting things on the horizon for cervical cancer. You know, for so long, we were stuck with the same treatments for cervical cancer. A while ago we had a new treatment that really revolutionized how we treat advanced stage or recurrent cancer. But then it had been about a decade until we had almost anything more.
And now we have the inclusion of immunotherapy both in the initial treatment of locally advanced cancer and metastatic or advanced cancer and also in recurrent disease. And now we have these antibody drug conjugates that have just come out, which help us manage recurrent disease as well. So all of these are really exciting things on the horizon, and they have been only made possible with really active clinical trials.
My [ACT]IVATION tip for this question is to remember how far we’ve come in just even a short amount of time and all of these new advancements and thinking about that these advancements have only been made possible with clinical trials. So more clinical trials are in the pipeline. I really encourage providers and patients to think and consider clinical trials when they’re at a juncture point of their cancer-directed therapy so that we can learn even more about the best ways of treating cervical cancer.